Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic
Giorgio Bogani(Fondazione IRCCS Istituto Nazionale dei Tumori), Tommaso Simoncini(University of Pisa), Anna Chiara Boschi(Ospedale "Santa Maria delle Croci" di Ravenna), Antonio Cianci(Agostino Gemelli University Polyclinic), S. Montoli(Azienda Ospedaliera Ospedale Civile di Legnano), Ruby Martinello, Anna Myriam Perrone(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Francesco Sopracordevole(Centro di Riferimento Oncologico), Chiara Cimmino(University of Insubria), Giovanni Scambia(Agostino Gemelli University Polyclinic), Tommaso Grassi(Azienda Ospedaliera San Gerardo), Gabriella Ferrandina(Agostino Gemelli University Polyclinic), Vito Chiàntera(University of Palermo), Simone Ferrero(Ospedale Policlinico San Martino), Maria Grazia Matarazzo(University of Catania), Federico Ferrari(University of Brescia), Vito Andrea Capozzi(University of Parma), Francesco Multinu(European Institute of Oncology), Fabio Barra(Institute for Health Metrics and Evaluation), Gabriele Centini(University of Siena), Roberto Berretta(University of Parma), Giuseppe Sarpietro(University of Catania), Fulvio Zullo(Magna Graecia University), Giuseppe Comerci(Ospedale "Santa Maria delle Croci" di Ravenna), Fabio Ghezzi(University of Insubria), Jvan Casarin(University of Insubria), Fabio Landoni(University of Milan), Vanna Zanagnolo(European Institute of Oncology), Giorgio Giorda(Centro di Riferimento Oncologico), Matteo Loverro(Agostino Gemelli University Polyclinic), Barbara Costantini(Università Cattolica del Sacro Cuore), Pantaleo Greco(University of Ferrara), Silvia Corso(Alessandro Manzoni Hospital), Enrico Sartori(Mylan (Switzerland)), Umberto Leone Roberti Maggiore(Fondazione IRCCS Istituto Nazionale dei Tumori), Luca Bazzurini(Azienda Ospedaliera San Gerardo), Pierandrea De Iaco(Clinical Orthopaedics and Related Research), Gabriele Siesto(University of Insubria), Stefano Cianci(Università Cattolica del Sacro Cuore), Marta Caretto(University of Pisa), Errico Zupi(University of Siena), Nicoletta Biglia(A. O. Ordine Mauriziano di Torino), Antonio Pellegrino(Ospedale Vito Fazzi), Michele Morelli(Ospedale Annunziata di Cosenza), Stefania Stevenazzi(Azienda Ospedaliera Ospedale Civile di Legnano), Francesco Fanfani(Agostino Gemelli University Polyclinic)
Cited by 16
Related Papers
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
ESHRE guideline: endometriosis
|Human Reproduction Open|2022|1.5k
Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group
|Ultrasound in Obstetrics and Gynecology|2016|882
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2013|607